Antibodies generated against recombinant streptococcal inhibitor of complement do not trigger detectable renal pathology in a Lewis rat model
Animal Models and Experimental Medicine · 16.11.2026
DOI: 10.1002/ame2.70305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 16.11.2026. Verfasst von Mohammad Raguib Munif und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Science and Technology, University of New England, Armidale, New South Wales, Australia. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of New England, National Health and Medical Research Council.
Abstract (Originalsprache)
Background
Post‐streptococcal glomerulonephritis (PSGN) is an immune‐mediated sequela of group A streptococcal (GAS) infections, with nephritogenic GAS antigens implicated in its pathogenesis. Seroepidemiological evidence also implicates GAS streptococcal inhibitor of complement (SIC) in the development of PSGN. This association is supported by elevated anti‐SIC antibody responses in patients with PSGN, suggesting a possible role for these antibodies in disease pathogenesis.
Methods
To investigate whether antibodies generated against SIC are associated with renal pathology, Lewis rats were administered recombinant SIC (rSIC), its domain containing the long repeat region (LRR) and proline‐rich region (PRR), or rSIC combined with inactivated whole‐cell GAS (IWG) in a series of experiments. Serum antibody responses were evaluated using enzyme‐linked immunosorbent assays. Renal alterations were assessed by biochemical analyses of serum and urinary albumin, creatinine, and urea; urinalysis for microhematuria and albumin‐to‐creatinine ratio; histopathology; and immunofluorescence analysis of immunoglobulin G (IgG) and complement C3 deposition. Systemic complement activation was evaluated by measuring serum C3a levels.
Results
Although robust anti‐SIC antibody responses ( p < 0.0001) were observed in all rats exposed to the various SIC formulations or domain, no renal functional impairment, histopathological injury, urinary abnormalities, or significant alterations in serum C3a levels were identified. In the absence of overt renal abnormalities, immunofluorescence revealed only focal low‐grade glomerular IgG deposition but no detectable C3 deposition.
Conclusions
In this Lewis rat model, antibodies to rSIC did not drive PSGN‐like renal pathology. This suggests that SIC‐specific humoral responses alone may be insufficient for disease development, potentially reflecting the multifactorial nature of PSGN pathogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Science and Technology, University of New England, Armidale, New South Wales, Australia.
- Department of Surgery and Obstetrics, Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh, Bangladesh.
- School of Science, Technology, Engineering and Genecology Research Centre, University of the Sunshine Coast, Sippy Downs, Queensland, Australia.
ORCID-Profile: Mohammad Raguib Munif, Rukshan A M Rafeek, Robert A Hart, Kirstan A Vessey, David J McMillan, Kadaba S Sriprakash, Natkunam Ketheesan
Förderung
- University of New England
- National Health and Medical Research Council
Zitieren
APA
Munif, M. R., Rafeek, R. A. M., Hart, R. A., Vessey, K. A., McMillan, D. J., Sriprakash, K. S., & Ketheesan, N. (2026). Antibodies generated against recombinant streptococcal inhibitor of complement do not trigger detectable renal pathology in a Lewis rat model. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70305
Vancouver
Munif MR, Rafeek RAM, Hart RA, Vessey KA, McMillan DJ, Sriprakash KS, et al. Antibodies generated against recombinant streptococcal inhibitor of complement do not trigger detectable renal pathology in a Lewis rat model. Animal Models and Experimental Medicine. 2026. doi:10.1002/ame2.70305
BibTeX
@article{Munif2026,
author = {Munif, Mohammad Raguib and Rafeek, Rukshan A M and Hart, Robert A and Vessey, Kirstan A and McMillan, David J and Sriprakash, Kadaba S and Ketheesan, Natkunam},
title = {Antibodies generated against recombinant streptococcal inhibitor of complement do not trigger detectable renal pathology in a Lewis rat model},
journal = {Animal Models and Experimental Medicine},
year = {2026},
doi = {10.1002/ame2.70305}
}
EUVIMED